A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Gabapentin has become the 5th most prescribed drug. It's also getting a bad reputation. Here's why it doesn't deserve it, ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Mochi Health offers two subscription-based weight loss programs: Mochi Health and Wellness Plus. While anyone can access the ...

Science must guide treatment decisions, and healthcare practitioners must take decisive action now to stop inappropriate fibrate prescribing for cardiovascular risk reduction, especially on top of ...

The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they've had such an event already, Novo Nordisk ...

An oral GLP-1 receptor agonist, Rybelsus will be available in 7-mg and 14-mg doses. "As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new ...

The Food and Drug Administration approved Novo Nordisk’s NOVO.B-0.26%decrease; red down pointing triangle oral GLP-1 medication to reduce the risk of major cardiovascular events in high-risk adults ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months. The agency in July accepted an application for Denali's enzyme replacement ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...